{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T02:14:03Z","timestamp":1778033643117,"version":"3.51.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lab Anim Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Sepsis is a common complication of parenteral nutrition therapy for infants with intestinal failure, due to the presence of a central venous catheter and impairment of gut barrier function. Intestinal failure-associated liver disease (IFALD) is another complication, often attributed to the type of intravenous lipid emulsion delivered and this is commonly studied in pre-clinical animal models. Animal studies frequently overlook sepsis as a confounding factor, potentially biasing the results. We retrospectively reviewed 14-day studies of total parenteral nutrition (TPN) in piglets in our laboratory from 2011 to 2025, to determine if sepsis is an independent predictor of key liver outcomes relevant to IFALD research. Sepsis was defined as positive blood culture.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 86 piglets (76 male; aged 2\u20135 days) were eligible for inclusion across four experimental studies. In total, 44 (51%) were suspected to have sepsis on the basis of clinical signs, 4 had missing blood cultures, and of these 28\/40 (70%) had a positive blood culture. Septic piglets had higher mortality compared to those not suspected to be septic or having a negative blood culture (43% vs. 9%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Septic piglets showed significantly lower bile flow (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and higher serum total bilirubin (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) compared to non-septic piglets. The risk of developing sepsis was reduced in piglets with older age (OR\u2009=\u20090.42,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.007) and increased when given a pure soy-oil compared to pure fish-oil emulsion (OR\u2009=\u200910.77,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.05). Multivariate analysis showed the independent predictors of bile flow were both sepsis (negative) and higher body weight at study entry (positive) (R\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u20090.42,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), while sepsis and use of a soy-based lipid emulsion were independent positive predictors of total bilirubin (R\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u20090.34,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Sepsis is associated with reduced bile flow, elevated total bilirubin and increased mortality in PN fed neonatal piglets. As sepsis can be a confounding factor in liver outcomes, researchers should both introduce refinements to mitigate sepsis as well as consistently report on the number of animals with sepsis within treatment groups and their outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s42826-026-00279-5","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T01:35:27Z","timestamp":1778031327000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sepsis as a confounding factor in assessing liver dysfunction in parenterally fed piglets: a model for human infants with intestinal failure"],"prefix":"10.1186","volume":"42","author":[{"given":"Mahabub","family":"Alam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela R.","family":"Wizzard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick N.","family":"Nation","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Zaugg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul W.","family":"Wales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3517-636X","authenticated-orcid":false,"given":"Justine M.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,6]]},"reference":[{"issue":"1","key":"279_CR1","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/jpen.2232","volume":"46","author":"BP Modi","year":"2022","unstructured":"Modi BP, Galloway DP, Gura K, Nucci A, Plogsted S, Tucker A, et al. ASPEN definitions in pediatric intestinal failure. J Parenter Enter Nutr. 2022;46(1):42\u201359.","journal-title":"J Parenter Enter Nutr"},{"issue":"6","key":"279_CR2","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1097\/MPG.0000000000002313","volume":"68","author":"DM Isaac","year":"2019","unstructured":"Isaac DM, Alzaben AS, Mazurak VC, Yap J, Wizzard PR, Nation PN, et al. Mixed lipid, fish oil, and soybean oil parenteral lipids impact cholestasis, hepatic phytosterol, and lipid composition. J Pediatr Gastroenterol Nutr. 2019;68(6):861\u20137.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"5","key":"279_CR3","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1177\/0148607111413598","volume":"35","author":"IR Diamond","year":"2011","unstructured":"Diamond IR, De Silva NT, Tomlinson GA, Pencharz PB, Feldman BM, Moore AM, et al. The role of parenteral lipids in the development of advanced intestinal failure-associated liver disease in infants: A multiple-variable analysis. J Parenter Enter Nutr. 2011;35(5):596\u2013602.","journal-title":"J Parenter Enter Nutr"},{"issue":"3","key":"279_CR4","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1097\/MPG.0000000000002794","volume":"71","author":"JA Silverman","year":"2020","unstructured":"Silverman JA, Turner JM, Wales PW. Composite lipid emulsion for the infant at risk of intestinal failure-associated liver disease: the Canadian perspective. J Pediatr Gastroenterol Nutr. 2020;71(3):283\u20137.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"2","key":"279_CR5","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1093\/ajcn\/nqz110","volume":"110","author":"ACS Pierret","year":"2019","unstructured":"Pierret ACS, Wilkinson JT, Zilbauer M, Mann JP. Clinical outcomes in pediatric intestinal failure: A meta-analysis and meta-regression. Am J Clin Nutr. 2019;110(2):430\u20136.","journal-title":"Am J Clin Nutr"},{"issue":"8","key":"279_CR6","doi-asserted-by":"publisher","first-page":"e13580","DOI":"10.1111\/petr.13580","volume":"23","author":"VK Raghu","year":"2019","unstructured":"Raghu VK, Beaumont JL, Everly MJ, Venick RS, Lacaille F, Mazariegos GV. Pediatric intestinal transplantation: Analysis of the intestinal transplant registry. Pediatr Transpl. 2019;23(8):e13580.","journal-title":"Pediatr Transpl"},{"issue":"4","key":"279_CR7","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.jpeds.2012.03.062","volume":"161","author":"RH Squires","year":"2012","unstructured":"Squires RH, Duggan C, Teitelbaum DH, Wales PW, Balint J, Venick R, et al. Natural history of pediatric intestinal failure: Initial report from the pediatric intestinal failure consortium. J Pediatr. 2012;161(4):723\u20138. e2.","journal-title":"J Pediatr"},{"issue":"7","key":"279_CR8","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1177\/0148607115579711","volume":"40","author":"JM Turner","year":"2016","unstructured":"Turner JM, Josephson J, Field CJ, Wizzard PR, Ball RO, Pencharz PB, et al. Liver disease, systemic inflammation, and growth using a mixed parenteral lipid emulsion, containing soybean oil, fish oil, and medium chain triglycerides, compared with soybean oil in parenteral nutrition-fed neonatal piglets. J Parenter Enter Nutr. 2016;40(7):973\u201381.","journal-title":"J Parenter Enter Nutr"},{"issue":"2","key":"279_CR9","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1203\/00006450-199902000-00008","volume":"45","author":"JE Van Aerde","year":"1999","unstructured":"Van Aerde JE, Duerksen DR, Gramlich L, Meddings JB, Chan G, Thomson ABR, et al. Intravenous fish oil emulsion attenuates total parenteral nutrition- induced cholestasis in newborn piglets. Pediatr Res. 1999;45(2):202\u20138.","journal-title":"Pediatr Res"},{"issue":"3","key":"279_CR10","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1194\/jlr.M044545","volume":"55","author":"H Vlaardingerbroek","year":"2014","unstructured":"Vlaardingerbroek H, Ng K, Stoll B, Benight N, Chacko S, Kluijtmans LAJ, et al. New generation lipid emulsions prevent PNALD in chronic parenterally fed preterm pigs. J Lipid Res. 2014;55(3):466\u201377.","journal-title":"J Lipid Res"},{"issue":"3","key":"279_CR11","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.tjnut.2024.10.047","volume":"155","author":"E Lucchinetti","year":"2025","unstructured":"Lucchinetti E, Lou PH, Chakravarty A, Marcolla CS, Pauline ML, Wizzard PR, et al. The novel lipid emulsion vegaven is well tolerated and elicits distinct biological actions compared with a mixed-oil lipid emulsion containing fish oil: A parenteral nutrition trial in piglets. J Nutr. 2025;155(3):703\u201318.","journal-title":"J Nutr"},{"issue":"21","key":"279_CR12","doi-asserted-by":"publisher","first-page":"15821","DOI":"10.3390\/ijms242115821","volume":"24","author":"S Lange","year":"2023","unstructured":"Lange S, Inal JM. Animal models of human disease. Int J Mol Sci. 2023;24(21):15821.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"279_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/MPG.0b013e3181f18ca0","volume":"52","author":"JM Turner","year":"2011","unstructured":"Turner JM, Wales PW, Nation PN, Wizzard P, Pendlebury C, Sergi C, et al. Novel neonatal piglet models of surgical short bowel syndrome with intestinal failure. J Pediatr Gastroenterol Nutr. 2011;52(1):9\u201316.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"279_CR14","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.hbpd.2022.12.004","volume":"23","author":"SY Cheng","year":"2024","unstructured":"Cheng SY, Jiang L, Wang Y, Cai W. Emerging role of regulated cell death in intestinal failure-associated liver disease. Hepatobiliary Pancreat Dis Int. 2024;23(3):228\u201333.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"2 SUPPL1","key":"279_CR15","doi-asserted-by":"publisher","first-page":"S70","DOI":"10.1053\/j.gastro.2005.10.066","volume":"130","author":"DA Kelly","year":"2006","unstructured":"Kelly DA. Intestinal failure-associated liver disease: What do we know today? Gastroenterology. 2006;130(2 SUPPL1):S70\u20137.","journal-title":"Gastroenterology"},{"issue":"6","key":"279_CR16","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3109\/08830185.2014.889129","volume":"33","author":"J Yan","year":"2014","unstructured":"Yan J, Li S, Li S. The role of the liver in sepsis. Int Rev Immunol. 2014;33(6):498.","journal-title":"Int Rev Immunol"},{"issue":"1","key":"279_CR17","doi-asserted-by":"publisher","first-page":"E6","DOI":"10.1111\/jpc.12053","volume":"49","author":"H Oswari","year":"2013","unstructured":"Oswari H, Widjaja RK, Rohsiswatmo R, Cleghorn G. Prognostic value of biochemical liver parameters in neonatal sepsis-associated cholestasis. J Paediatr Child Health. 2013;49(1):E6\u201311.","journal-title":"J Paediatr Child Health"},{"key":"279_CR18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.clnu.2024.12.014","volume":"45","author":"D Gattini","year":"2025","unstructured":"Gattini D, Murphy A, Belza C, Avitzur Y, Wales PW. Are enteral devices risk factors for central line-associated bloodstream infections in children with intestinal failure? Clin Nutr. 2025;45:75\u201380.","journal-title":"Clin Nutr"},{"issue":"4","key":"279_CR19","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/jpen.2609","volume":"48","author":"ML Pauline","year":"2024","unstructured":"Pauline ML, Labonne E, Wizzard PR, Turner JM, Wales PW. Association between 4%-tetrasodium EDTA and sepsis in neonatal piglets: A retrospective cohort study. J Parenter Enter Nutr. 2024;48(4):495\u2013501.","journal-title":"J Parenter Enter Nutr"},{"issue":"6","key":"279_CR20","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1002\/jpen.1989","volume":"45","author":"J Quirt","year":"2021","unstructured":"Quirt J, Belza C, Pai N, Clause RF, Markovic F, Wong-Sterling S, et al. Reduction of central line-associated bloodstream infections and line occlusions in pediatric intestinal failure patients receiving long-term parenteral nutrition using an alternative locking solution, 4% tetrasodium ethylenediaminetetraacetic acid. J Parenter Enter Nutr. 2021;45(6):1286\u201392.","journal-title":"J Parenter Enter Nutr"},{"issue":"1","key":"279_CR21","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/jpen.2551","volume":"48","author":"D Gattini","year":"2024","unstructured":"Gattini D, Yan H, Belza C, Avitzur Y, Wales PW. Cost-utility analysis of 4% tetrasodium ethylenediaminetetraacetic acid, taurolidine, and heparin lock to prevent central line-associated bloodstream infections in children with intestinal failure. J Parenter Enter Nutr. 2024;48(1):47\u201356.","journal-title":"J Parenter Enter Nutr"},{"issue":"4","key":"279_CR22","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1177\/1129729820946916","volume":"22","author":"J Hill","year":"2021","unstructured":"Hill J, Garner R. Efficacy of 4% tetrasodium ethylenediaminetetraacetic acid (T-EDTA) catheter lock solution in home parenteral nutrition patients: A quality improvement evaluation. J Vasc Access. 2021;22(4):533\u20139.","journal-title":"J Vasc Access"},{"issue":"1","key":"279_CR23","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/2049-1891-3-42","volume":"3","author":"RA Cabrera","year":"2012","unstructured":"Cabrera RA, Lin X, Campbell JM, Moeser AJ, Odle J. Influence of birth order, birth weight, colostrum and serum immunoglobulin G on neonatal piglet survival. J Anim Sci Biotechnol. 2012;3(1):42.","journal-title":"J Anim Sci Biotechnol"},{"issue":"3","key":"279_CR24","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/jpen.1667","volume":"44","author":"TB Seddik","year":"2020","unstructured":"Seddik TB, Tian L, Nespor C, Kerner J, Maldonado Y, Gans H. Risk factors of ambulatory central line\u2013associated bloodstream infection in pediatric short bowel syndrome. J Parenter Enter Nutr. 2020;44(3):500\u20136.","journal-title":"J Parenter Enter Nutr"},{"issue":"5","key":"279_CR25","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1093\/ajcn\/67.5.927","volume":"67","author":"P Lenssen","year":"1998","unstructured":"Lenssen P, Bruemmer BA, Bowden RA, Gooley T, Aker SN, Mattson D. Intravenous lipid dose and incidence of bacteremia and fungemia in patients undergoing bone marrow transplantation. Am J Clin Nutr. 1998;67(5):927\u201333.","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"279_CR26","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1177\/0148607111420061","volume":"36","author":"A Pontes-Arruda","year":"2012","unstructured":"Pontes-Arruda A, Liu FX, Turpin RS, Mercaldi CJ, Hise M, Zaloga G. Bloodstream infections in patients receiving manufactured parenteral nutrition with vs without lipids: is the use of lipids really deleterious? J Parenter Enter Nutr. 2012;36(4):421\u201330.","journal-title":"J Parenter Enter Nutr"},{"issue":"5","key":"279_CR27","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00431-011-1619-y","volume":"171","author":"B Shouman","year":"2012","unstructured":"Shouman B, Abdel-Hady H, Badr RI, Hammad E, Salama MF. Dose of intravenous lipids and rate of bacterial clearance in preterm infants with blood stream infections. Eur J Pediatr. 2012;171(5):811\u20136.","journal-title":"Eur J Pediatr"}],"container-title":["Laboratory Animal Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42826-026-00279-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42826-026-00279-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42826-026-00279-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T01:35:35Z","timestamp":1778031335000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s42826-026-00279-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,6]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["279"],"URL":"https:\/\/doi.org\/10.1186\/s42826-026-00279-5","relation":{},"ISSN":["2233-7660"],"issn-type":[{"value":"2233-7660","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,6]]},"assertion":[{"value":"26 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study analyzed data from four previous experiments in our laboratory, each of which had individual ethics approved (AUP00003707) and procedures were conducted in accordance with the Canadian Council on Animal Care Guidelines and approved by the University of Alberta Animal Care and Use Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All authors consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Authors have no conflict of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18"}}